| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3774726
[patent_doc_number] => 05850002
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Animal models for loss and gain of Hox11 function'
[patent_app_type] => 1
[patent_app_number] => 8/712948
[patent_app_country] => US
[patent_app_date] => 1996-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 9454
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/850/05850002.pdf
[firstpage_image] =>[orig_patent_app_number] => 712948
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/712948 | Animal models for loss and gain of Hox11 function | Sep 12, 1996 | Issued |
| 08/693865 | BACTERIOPHAGE-MEDIATED GENE THERAPY | Aug 4, 1996 | Pending |
Array
(
[id] => 3773075
[patent_doc_number] => 05817492
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Recombinant DNA viral vector for transfecting animal cells'
[patent_app_type] => 1
[patent_app_number] => 8/521575
[patent_app_country] => US
[patent_app_date] => 1995-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10428
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817492.pdf
[firstpage_image] =>[orig_patent_app_number] => 521575
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/521575 | Recombinant DNA viral vector for transfecting animal cells | Aug 29, 1995 | Issued |
Array
(
[id] => 3451197
[patent_doc_number] => 05378459
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-03
[patent_title] => 'Pharmaceutical preparation in the treatment of tonsillitis'
[patent_app_type] => 1
[patent_app_number] => 8/194753
[patent_app_country] => US
[patent_app_date] => 1994-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3086
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/378/05378459.pdf
[firstpage_image] =>[orig_patent_app_number] => 194753
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/194753 | Pharmaceutical preparation in the treatment of tonsillitis | Feb 9, 1994 | Issued |
Array
(
[id] => 3485133
[patent_doc_number] => 05425940
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-20
[patent_title] => 'Combination therapy using interleukin-2 and tumor necrosis factor'
[patent_app_type] => 1
[patent_app_number] => 8/191277
[patent_app_country] => US
[patent_app_date] => 1994-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13338
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/425/05425940.pdf
[firstpage_image] =>[orig_patent_app_number] => 191277
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/191277 | Combination therapy using interleukin-2 and tumor necrosis factor | Feb 2, 1994 | Issued |
Array
(
[id] => 3424146
[patent_doc_number] => 05403585
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-04
[patent_title] => 'Therapeutic use of enkephalinase'
[patent_app_type] => 1
[patent_app_number] => 8/134970
[patent_app_country] => US
[patent_app_date] => 1993-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 24
[patent_no_of_words] => 14554
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/403/05403585.pdf
[firstpage_image] =>[orig_patent_app_number] => 134970
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/134970 | Therapeutic use of enkephalinase | Oct 11, 1993 | Issued |
Array
(
[id] => 3415317
[patent_doc_number] => 05433955
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-07-18
[patent_title] => 'Site specific in vivo activation of therapeutic drugs'
[patent_app_type] => 1
[patent_app_number] => 8/134520
[patent_app_country] => US
[patent_app_date] => 1993-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 13
[patent_no_of_words] => 8241
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/433/05433955.pdf
[firstpage_image] =>[orig_patent_app_number] => 134520
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/134520 | Site specific in vivo activation of therapeutic drugs | Oct 7, 1993 | Issued |
| 08/131879 | USE OF TRANSGLUTAMINASES AS IMMUNOSUPPRESSANTS | Oct 4, 1993 | Abandoned |
Array
(
[id] => 2994189
[patent_doc_number] => 05366958
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-22
[patent_title] => 'Localized delivery using fibronectin conjugates'
[patent_app_type] => 1
[patent_app_number] => 8/110193
[patent_app_country] => US
[patent_app_date] => 1993-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6880
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/366/05366958.pdf
[firstpage_image] =>[orig_patent_app_number] => 110193
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/110193 | Localized delivery using fibronectin conjugates | Aug 19, 1993 | Issued |
Array
(
[id] => 3106113
[patent_doc_number] => 05413784
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-09
[patent_title] => 'Biopesticide composition and process for controlling insect pests'
[patent_app_type] => 1
[patent_app_number] => 8/058795
[patent_app_country] => US
[patent_app_date] => 1993-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8472
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/413/05413784.pdf
[firstpage_image] =>[orig_patent_app_number] => 058795
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/058795 | Biopesticide composition and process for controlling insect pests | May 9, 1993 | Issued |
| 08/037885 | USE OF A COL1A1 MINI-GENE CONSTRUCT TO INHIBIT COLLAGEN SYNTHESIS | Mar 25, 1993 | Pending |
Array
(
[id] => 3441736
[patent_doc_number] => 05419901
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-30
[patent_title] => 'Use of arginase to control nitric oxide formation'
[patent_app_type] => 1
[patent_app_number] => 8/020998
[patent_app_country] => US
[patent_app_date] => 1993-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2636
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/419/05419901.pdf
[firstpage_image] =>[orig_patent_app_number] => 020998
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/020998 | Use of arginase to control nitric oxide formation | Feb 21, 1993 | Issued |
| 07/999186 | BIOLOGICAL CONTROL OF COCKROCHAES AND CARPENTER ANTS WITH A FUNGAL PATHOGEN | Dec 29, 1992 | Abandoned |
| 07/999185 | BIOLOGICAL CONTROL OF COCKROACHES, CARPENTER ANTS, AND PHARAOH ANTS WITH A FUNGAL PATHOGEN | Dec 29, 1992 | Abandoned |
Array
(
[id] => 3049592
[patent_doc_number] => 05344647
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-06
[patent_title] => 'Strain of microorganism having antimicrobial activity'
[patent_app_type] => 1
[patent_app_number] => 7/998640
[patent_app_country] => US
[patent_app_date] => 1992-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3632
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/344/05344647.pdf
[firstpage_image] =>[orig_patent_app_number] => 998640
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/998640 | Strain of microorganism having antimicrobial activity | Dec 28, 1992 | Issued |
| 90/002908 | LACTOFERRIN AS A DIETARY INGREDIENT PROMOTING THE GROWTH OF THE GASTROINTESTINAL TRACT | Dec 21, 1992 | Issued |
Array
(
[id] => 3025789
[patent_doc_number] => 05342616
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-08-30
[patent_title] => 'Method of administering tissue plasminogen activator'
[patent_app_type] => 1
[patent_app_number] => 7/994083
[patent_app_country] => US
[patent_app_date] => 1992-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3385
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/342/05342616.pdf
[firstpage_image] =>[orig_patent_app_number] => 994083
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/994083 | Method of administering tissue plasminogen activator | Dec 15, 1992 | Issued |
| 07/985478 | GENE THERAPY FOR CYSTIC FIBROSIS | Dec 2, 1992 | Abandoned |
Array
(
[id] => 3103664
[patent_doc_number] => 05407671
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-18
[patent_title] => 'One-component tissue adhesive and a process for the production thereof'
[patent_app_type] => 1
[patent_app_number] => 7/983613
[patent_app_country] => US
[patent_app_date] => 1992-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2534
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/407/05407671.pdf
[firstpage_image] =>[orig_patent_app_number] => 983613
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/983613 | One-component tissue adhesive and a process for the production thereof | Nov 29, 1992 | Issued |
Array
(
[id] => 3441814
[patent_doc_number] => 05419906
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-30
[patent_title] => 'Preparation of human immunoglobulin free of hepatitis C'
[patent_app_type] => 1
[patent_app_number] => 7/965658
[patent_app_country] => US
[patent_app_date] => 1992-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4403
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/419/05419906.pdf
[firstpage_image] =>[orig_patent_app_number] => 965658
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/965658 | Preparation of human immunoglobulin free of hepatitis C | Oct 22, 1992 | Issued |